Ayala Pharmaceuticals, Inc. (AYLA) Stock Analysis
DELISTED 2023
What happened to Ayala Pharmaceuticals, Inc. (AYLA) stock?
Ayala Pharmaceuticals, Inc. (AYLA) no longer trades on public markets. It was delisted in January 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2023
- Last recorded price (historical):
- $0.5339 (last quote on record before the January 2023 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ayala Pharmaceuticals, Inc. (AYLA). Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for rare cancers. Their lead product candidates target Notch-activating mutations in adenoid cystic carcinoma and desmoid tumors.
Last analyzed: Mar 18, 2026Ayala Pharmaceuticals, Inc. (AYLA) Healthcare & Pipeline Overview
More about this archive record
Can I still buy AYLA shares?
No. AYLA stopped trading on public markets in January 2023, so the shares are not available through a broker. Anything you see quoted for AYLA elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AYLA stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ayala Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.